Shiga Toxin-Producing Escherichia coli in Certain Raw Beef Products, 31975-31981 [2012-13283]
Download as PDF
31975
Rules and Regulations
Federal Register
Vol. 77, No. 105
Thursday, May 31, 2012
This section of the FEDERAL REGISTER
contains regulatory documents having general
applicability and legal effect, most of which
are keyed to and codified in the Code of
Federal Regulations, which is published under
50 titles pursuant to 44 U.S.C. 1510.
The Code of Federal Regulations is sold by
the Superintendent of Documents. Prices of
new books are listed in the first FEDERAL
REGISTER issue of each week.
DEPARTMENT OF AGRICULTURE
Food Safety and Inspection Service
9 CFR Parts 416, 417, and 430
[Docket No. FSIS–2010–0023]
Shiga Toxin-Producing Escherichia
coli in Certain Raw Beef Products
Food Safety and Inspection
Service, USDA.
ACTION: Response to comments on final
determination; planned implementation
for testing raw beef manufacturing
trimmings.
AGENCY:
The Food Safety and
Inspection Service (FSIS) is confirming
that it will implement routine
verification testing for six Shiga toxinproducing Escherichia coli (STEC), in
addition to E. coli O157:H7, in raw beef
manufacturing trimmings beginning
June 4, 2012. FSIS is also responding to
comments on the final determination
published September 20, 2011, in the
Federal Register regarding the June 4,
2012, implementation of STEC sampling
and related issues.
DATES: Beginning June 4, 2012, FSIS
will implement routine verification
testing for the six additional STECs
discussed in this document (O26, O45,
O103, O111, O121, and O145), in raw
beef manufacturing trimmings (domestic
or imported) derived from cattle
slaughtered on or after June 4, 2012. To
allow industry time to implement any
appropriate changes in food safety
systems, including control procedures
in their processes, FSIS will generally
not regard raw, non-intact beef products
or the components of these products
found to have these pathogens as
adulterated until June 4, 2012. FSIS will
announce in a future Federal Register
document the date it intends to
implement routine verification testing
for the specified STECs in additional
mstockstill on DSK4VPTVN1PROD with RULES1
SUMMARY:
VerDate Mar<15>2010
16:27 May 30, 2012
Jkt 226001
raw beef products tested by FSIS for E.
coli O157:H7, including ground beef.
FOR FURTHER INFORMATION CONTACT:
Rachel Edelstein, Acting Assistant
Administrator, Office of Policy and
Program Development, Food Safety and
Inspection Service, U.S. Department of
Agriculture, (202) 205–0495.
SUPPLEMENTARY INFORMATION:
Background
On September 20, 2011, FSIS
published a document in the Federal
Register announcing its determination
that raw, non-intact beef products, or
raw, intact beef products that are
intended for use in raw non-intact
product, that are contaminated with
Shiga toxin-producing Escherichia coli
(STEC) O26, O45, O103, O111, O121,
and O145 are adulterated within the
meaning of 21 U.S.C. 601(m)(1) (76 FR
58157; Sep. 20, 2011). The products are
adulterated because they contain a
poisonous or deleterious substance that
may render them injurious to health.
FSIS stated that raw, non-intact beef
products that are contaminated with
these STEC are also unhealthful and
unwholesome (under 21 U.S.C.
601(m)(1) and (m)(3)) (76 FR 58157 at 76
FR 58159). FSIS also considers intact
cuts that are contaminated with these
pathogens to be adulterated,
unhealthful, and unfit for human food if
they are to be further processed into
raw, non-intact products before being
distributed for consumption (76 FR
58157 at 76 FR 58159).
FSIS announced that it intended to
implement sampling and testing for the
six non-O157 STEC, as it already does
for E. coli O157:H7. The Agency said
that it would begin this verification and
testing program on March 5, 2012. The
Agency noted that it would initially
sample only raw beef manufacturing
trimmings and other ground beef
components for the six non-O157 STEC,
but that it would consider other
products, including raw ground beef
contaminated with these STEC, to be
adulterated (at 76 FR 58160). The
Agency asked for comments on its plans
for implementing the program (at 76 FR
58157, 58164).
In addition, FSIS asked for comments
on Agency plans for a baseline survey
of the prevalence of the specified STEC
in raw beef products, whether to hold
technical or other public meetings,
various cost estimates, the type of
PO 00000
Frm 00001
Fmt 4700
Sfmt 4700
outreach and information that would be
most useful to establishments preparing
for implementation by the Agency of its
sampling and verification testing
program, and information that foreign
governments might need to address
inspection equivalency or
implementation concerns.
FSIS extended the public comment
period from November 21, 2011, to
December 21, 2011, and held a public
meeting by teleconference on December
1, 2011. (76 FR 72331; Nov. 23, 2011).
In response to comments received
from industry, FSIS issued a Federal
Register notice (77 FR 9888; Feb. 21,
2012) in which FSIS moved the
implementation date to June 4, 2012, for
routine verification activities, including
testing, for the six specified STEC in
raw beef manufacturing trimmings
derived from cattle slaughtered on or
after June 4, 2012. To allow
establishments time to implement
appropriate changes in their food safety
systems, including changes in process
control procedures, FSIS will generally
not treat as adulterated raw beef
products found to have these pathogens
until June 4, 2012. Additionally, FSIS
will begin conducting for-cause food
safety assessments (FSAs) in response to
FSIS positive non-O157 STEC results
approximately 90 days after FSIS
implements non-O157 STEC sampling
and testing in beef manufacturing
trimmings. This 90-day period will
provide establishments sufficient time
to make any necessary changes to their
food safety systems.
When FSIS laboratories analyze the
samples, FSIS anticipates that there will
be some samples that will, in the first
stage of the FSIS screen test, test
positive for Shiga toxin gene (stx) and
for the intimin gene (eae) but screen
negative for all the target O-groups (O26,
O45, O103, O111, O121, and O145).
Such samples will be referred to the
USDA-Agricultural Research Service
(ARS) for further microbiological
analysis to determine whether they are
positive for other target O-groups. FSIS
expects to collect and analyze these
screen results from its verification tests
for at least the first year of testing. FSIS
will not consider the product associated
with non-confirmed results to be
adulterated. FSIS believes that the
information on these screen results will
be useful to establishments in
enhancing the preventive controls in
E:\FR\FM\31MYR1.SGM
31MYR1
31976
Federal Register / Vol. 77, No. 105 / Thursday, May 31, 2012 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES1
their food safety systems and believes
that establishments will benefit from
knowing whether they have screenpositive but not confirmed sample
results for E. coli O157:H7 or the
specified non-O157 STECs. Therefore,
FSIS is contemplating providing
individual establishments with this
information every quarter. In addition,
FSIS expects to regularly make aggregate
information known to stakeholders in
order for stakeholders to be aware of
and to consider the relevance of the
information.
FSIS, as a public health regulatory
agency, has adopted a preventive, risk
mitigation strategy that takes into
consideration the fact that the specified
STECs are adulterants of certain raw
beef products. In support of this
strategy, FSIS has finalized its risk
profile to reflect comments, the results
in a recent article on thermal resistance
of STEC-inoculated non-intact beef
steaks with strains of E. coli O157:H7
and non-O157 STEC (a pooled
composite of STEC serogroups O45,
O103, O111, O121, and O145) by
USDA–ARS (Luchansky et al., 2012),
and information from articles on how
much more common non-O157 STEC
infections are compared to E. coli
O157:H7 infections (Blanco et al., 2004;
Elliott et al., 2001; Nielsen et al., 2006;
Vally et al., 2012). The final risk profile
is available on the FSIS Web site at
https://www.fsis.usda.gov/Science/Risk_
Assessments/index.asp
In the September 20, 2011, Federal
Register, FSIS also announced the
availability of, and requested comments
on, the guidance document, Validation
Guidance for Pathogen Detection Test
Kits. FSIS explained that the Agency
prepared this guidance for the
validation of test kits for the detection
of pathogens, including both E. coli
O157:H7 and non-O157 STEC. FSIS
encouraged organizations that design or
conduct validation studies to avail
themselves of this guidance document
in meeting the pertinent regulatory
requirements. FSIS received numerous
comments on this document, will
update it as necessary in response to
comments, and will announce the
availability of the updated guidance
document when it is ready.
I. Implementation plan
In finalizing the plan for
implementing its verification activities,
including the sampling and testing
program for the specified STECs, FSIS
considered all comments submitted in
response to the September 2011 final
determination, as well as comments
provided at the December 1
teleconference, and is clarifying certain
VerDate Mar<15>2010
16:27 May 30, 2012
Jkt 226001
aspects of the implementation of the
verification activities.
FSIS will issue a Federal Register
notice announcing when FSIS will
begin routine sampling and testing for
the seven STECs of all raw beef
products subject to Agency E. coli
O157:H7 sampling and testing, from
both domestic and international
sources, regardless of the slaughter date
of cattle from which the product is
derived. When expanded testing begins,
mixtures of raw beef derived from cattle
slaughtered either before or after June 4,
2012, whether the production lot
contains raw beef manufacturing
trimmings, other raw ground beef
components, bench trim, or ground beef,
will be subject to testing for the seven
specified STECs.
The Agency is updating the economic
analysis published in the September 20,
2011, Federal Register notice in
response to public comments received.
To respond more thoroughly to the
comments, FSIS will incorporate any
additional data on establishment and
Agency testing for the specified STECs
that may be available upon FSIS’s
implementation of routine testing for
non-O157 STECs in beef manufacturing
trimmings. As indicated in the
September 20 notice (at 76 FR 58163),
the Agency will update and revise the
September 20, 2011, economic analysis,
will respond to comments received on
the earlier analysis, and will assess the
economic effects of testing for the
specified STECs on raw beef
manufacturing trimmings, other raw
ground beef components, and ground
beef. When the Agency completes the
updated analysis, FSIS will announce
its availability and request comments on
the analysis. The Agency will then
assess comments and make any
necessary changes before finalizing the
economic analysis and before expanding
FSIS testing to include other raw ground
beef components and ground product.
II. Comments and Responses
FSIS received approximately 34
comments in response to the September
2011 notice. Comments received from
consumer groups supported the
implementation of the final
determination that six additional STEC
serotypes are considered adulterants in
non-intact raw beef products and intact
beef products used to produce such
products and encouraged FSIS to resist
delaying the implementation date.
Several consumer advocacy groups,
citing the incidence of foodborne
disease caused by these organisms,
expressed support for FSIS’s final
determination. Comments submitted by
industry, trade associations, and foreign
PO 00000
Frm 00002
Fmt 4700
Sfmt 4700
countries expressed concerns about the
final determination and implementation
of the verification sampling and testing
program.
Following is a discussion of
comments that requested more
information or clarification regarding
the verification testing program that will
begin on June 4, 2012.
Delay Implementation
Comment: Many commenters
requested a delay of the implementation
date for the testing of the specified
STECs for various reasons, including
their view that FSIS needs to conduct a
baseline of non-O157 STECs on beef
products, needs to wait until
commercially available test kits for
these organisms become available and
can be validated, needs to hold a
technical meeting, and needs to conduct
a risk assessment.
Response: FSIS has concluded that a
baseline is neither necessary nor
warranted before implementation of the
FSIS verification sampling and testing
program. These organisms are present in
beef products in the United States; the
evidence for this is presented in the risk
profile. FSIS considers the data on nonO157 STECs obtained by the
Agricultural Research Service (ARS) at a
limited number of slaughter
establishments to be evidence that the
pathogens should be considered
adulterants and are capable of causing
illness. FSIS also considered data
collected by the person who petitioned
the Agency to declare these pathogens
to be adulterants in a limited
geographical retail area. The Agency has
concluded, on the basis of information
in a report from the Centers for Disease
Control and Prevention (CDC), that
these organisms pose a significant
public health burden in the United
States.1 FSIS and the CDC believe that
there are more unreported and
unconfirmed illnesses associated with
the specified non-O157 STECs than
with E. coli O157:H7.
Nonetheless, in 2013 FSIS intends to
conduct the carcass baseline survey
discussed in the September 20, 2011
Federal Register notice. This
microbiological survey will analyze
samples from carcasses for the presence
of the pathogens E. coli O157:H7 and
the specified STECs, Salmonella, and
indicator bacteria (generic E. coli,
coliforms, and Enterobacteriaceae). This
baseline will be designed to identify the
type, level, and frequency of
1 Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV,
Widdowson M-A, Roy SL, Jones JL, and Griffin PM.
2011. Foodborne illness acquired in the United
States—major pathogens. Emerg Infect Dis.
E:\FR\FM\31MYR1.SGM
31MYR1
mstockstill on DSK4VPTVN1PROD with RULES1
Federal Register / Vol. 77, No. 105 / Thursday, May 31, 2012 / Rules and Regulations
contamination of carcasses immediately
after hide removal but before
decontamination treatments and
evisceration. When the baseline study is
being developed, FSIS will share the
study design with stakeholders.
Regarding a baseline for raw beef
manufacturing trimmings, other raw
ground beef components, and ground
beef, FSIS is assessing its current
verification testing programs to see how
those programs can be modified to yield
on-going baseline information and
obviate the need for stand-alone
baseline studies.
At this time, FSIS is not planning to
host a technical meeting relating to nonO157 STEC. Commenters did not
identify any specific need for a
technical meeting. If there is evidence
that a technical meeting would be
helpful to industry, FSIS will, of course,
reconsider this issue.
Screening and confirmation methods
for non-O157 STEC are available to
industry. In addition, reagents are
commercially available to those
companies planning to use the FSIS
method. Some establishments have been
testing for non-O157 STECs for a year or
more.
Several companies have submitted
test kits to detect at least the six
specified STEC O-groups for review by
validation bodies. Using the FSIS
compliance guidelines related to
validating test kits, FSIS has reviewed
validation data from test kits and issued
no-objection-letters (NOLs) to several
manufacturers. The NOLs provide
establishments with supporting
documentation regarding the reliability
of verification testing results.
Confirmation testing is available to
industry through commercial reagents.
Regarding the contention that a risk
assessment is needed, the Agency has
assessed scientific data from several
fields on the risk posed by non-O157
STECs and determined that these
pathogens are adulterants under the
FMIA. To make this determination, the
Agency prepared a risk profile, which
has been independently peer reviewed
in accordance with Office of
Management and Budget (OMB)
guidelines. Both, the CDC and the Food
and Drug Administration (FDA)/Center
for Food Safety and Applied Nutrition
reviewed the document and provided
input on FSIS’ approach. The risk
profile lays out all available information
on the public health concerns posed by
these organisms and supports the
adulteration determination regarding
these E. coli serogroups.
VerDate Mar<15>2010
16:27 May 30, 2012
Jkt 226001
FSIS Sampling Plan
Comment: Several commenters stated
that FSIS has not adequately justified
the initiation of the non-O157 STEC
sampling program, given that non-O157
STECs are found at levels comparable to
E. coli O157:H7, and infection from the
non-O157 STEC tends to be less severe
than that from E. coli O157:H7. One
commenter questioned whether FSIS’s
testing program will be adequate for
determining process control and stated
that FSIS’s end-product testing will
have no impact other than to consume
resources that could be better spent on
food safety research.
Response: The FSIS verification
testing program is intended to assess
whether the industry, collectively, is
controlling for the presence of a
designated food safety hazard in
products regulated by FSIS. Adding the
six non-O157 STECs to the group of
pathogens for which FSIS tests will help
in improving food safety. The purpose
of the new testing program for non-O157
STECs is to verify that establishments
producing raw beef products have
adequately addressed these pathogens.
FSIS acknowledges that the best
approach to reducing STEC
contamination lies not in
comprehensive end-product testing but
in the development and implementation
of science-based preventive controls,
with end-product testing to verify
process control. FSIS’s non-O157 STEC
testing program will improve food safety
because FSIS anticipates that
establishments may voluntarily make
changes to their food safety systems in
response to the new testing. For
example, establishments may initiate a
testing program for non-O157 STECs or
may add new interventions to address
pathogens. FSIS is aware that some
companies have added new
bacteriophage interventions to address
non-O157 STEC. FSIS is not requiring
such changes but anticipates
establishments may make these types of
changes in response to the testing.
The non-O157 STECs may cause
illnesses of varying severity. Though
limited data are available on doseresponse, there is evidence that the
infectious doses of the pathogens are
relatively low. Hence, their potential to
cause illness is relatively high.
Although there is variability in
virulence severity of non-O157 STECs,
the six specified non-O157 STEC
organisms can cause severe foodborne
illness requiring hospitalization.
Numerous illnesses in the United States
have resulted from all six of the nonO157 STECs. CDC data show that the six
STEC organisms for which FSIS will be
PO 00000
Frm 00003
Fmt 4700
Sfmt 4700
31977
testing are known to cause more than 80
percent of human illnesses attributed to
non-O157 STEC.
The number of illnesses and deaths
caused by non-O157 STECs and
associated with beef consumption or a
beef source is likely to decline if
establishments voluntarily make
changes to their food safety system that
result in greater public health
protection. Also, FSIS’s current testing
for E. coli O157:H7 may not detect other
STECs that may be present in the
product.
Comment: One industry commenter
asked whether FSIS intends to collect
two samples for N–60 sampling, and if
so, would E. coli O157:H7 testing be
performed on one sample and non-O157
STEC testing on the other sample.
Another commenter noted that FSIS
does not specify the number of samples
it intends to collect in the sampling
plan.
Response: FSIS inspection personnel
will collect one N–60 sample (in
multiple containers) that will be tested
for all the STECs, including E. coli
O157:H7. Eventually, FSIS will analyze
all the raw beef samples collected for
both E. coli O157:H7 and non-O157
STEC.
Comment: Several commenters stated
that FSIS’s sampling plan should be
designed to estimate prevalence of the
STEC pathogens in raw beef products.
Response: FSIS verification testing
programs are not designed at this time
to assess statistically-based national
prevalence for select organisms. FSIS
verification testing assesses
establishment control of a food safety
hazard in products regulated by FSIS.
The number of tests FSIS will annually
conduct for non-O157 STECs will
exceed the number typically analyzed in
a structured baseline. Although FSIS’s
testing will not provide a true
prevalence estimate upon
implementation, it will provide helpful
information about whether
establishments’ food safety systems
adequately address food safety.
Comment: One commenter asked how
FSIS intends to increase its collection
rates for its beef manufacturing
trimmings testing program.
Response: The Agency has a number
of different initiatives underway to
increase its collection rates for the beef
manufacturing trimmings testing
programs. Importantly, the new Public
Health Information System (PHIS),
which is now implemented nationwide,
can schedule samples for laboratory
analysis. PHIS does so in a way that
ensures that requests are sent only to
establishments whose profiles
(information on establishment
E:\FR\FM\31MYR1.SGM
31MYR1
31978
Federal Register / Vol. 77, No. 105 / Thursday, May 31, 2012 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES1
characteristics) indicate that they are
producing the targeted product at the
time of sample scheduling. In addition,
if an establishment no longer makes the
product, PHIS allows inspection
program personnel to modify the
establishment profile (information on
establishment characteristics) to reflect
this change so that future samples are
not scheduled for that establishment.
FSIS Testing Method
Comment: One association questioned
whether the FSIS method published in
the Microbiology Laboratory Guidebook
(MLG) on November 4, 2011, was
appropriately peer-reviewed.
Commenters questioned whether
industry is required to test for non-O157
STECs, and whether industry would be
required to use the FSIS method.
Response: Initial results from the
method-development phase were
published in a peer-reviewed journal
with ARS and FSIS authors.2 The MLG
method was validated and then verified
for internal use by FSIS Laboratory
Services. In addition, when designing
the screening and confirmatory strategy
for the regulatory test, FSIS sought input
from the CDC, ARS, and the FDA and
worked closely with ARS in transferring
the method to use in the FSIS
laboratories.
FSIS is not requiring STEC testing by
industry, nor will it establish a
requirement for the FSIS testing
methodology to be used. Also, foreign
government central competent
authorities and foreign establishments
can determine what testing to conduct
and can use any test that they determine
is sufficient to identify the presence of
the specified STECs. As with the
domestic beef establishments, foreign
government central competent
authorities and foreign establishments
are expected to ensure that raw beef
product is controlled for the presence of
the specified non-O157 STECs.
Comment: One commenter asked
whether the most-probable-number
(MPN) enumeration was included in the
FSIS method.
Response: No, the FSIS MLG method
5B.01 as described does not include an
MPN method for enumerating non-O157
STEC in positive samples.
Comment: Several commenters
questioned the Agency’s statement
referring to expected establishment
actions following stx- or eae-positive
2 Fratamico, P.M., Bagi, L.K., Cray Jr, W.C.,
Narang, N., Medina, M.B., Liu, Y. Detection by
multiplex real-time PCR assays and isolation of
Shiga toxin-producing Escherichia coli serogroups
O26, O45, O103, O111, O121, and O145 in ground
beef. Foodborne Pathogens and Disease 2011;
8(5):601–7.
VerDate Mar<15>2010
16:27 May 30, 2012
Jkt 226001
first-stage screen results (at 76 FR
58161, col. 3): ‘‘A first-stage screen
positive (stx and eae) is evidence of the
presence of Shiga toxin and intimin and
may indicate that an establishment is
not adequately addressing hazards
reasonably likely to occur.
Establishments should reassess their
HACCP plans, Sanitation Standard
Operating Procedures, or other
prerequisite programs on the basis of
this evidence.’’ Commenters were
concerned that an establishment would
be required to reassess its Hazard
Analysis and Critical Control Point
(HACCP) plan after such results.
Response: The Agency regrets any
confusion that this statement created.
The first- and second-stage screening
steps of the FSIS method are performed
concurrently, not sequentially.
Establishments are not required to take
corrective actions or reassess their
HACCP plans in response to positive
FSIS screen results. However,
establishments would be required to
take corrective actions or reassess their
HACCP plans in response to FSIS
confirmed positive results for the
specified non-O157 STEC.
Some establishments may use the
FSIS laboratory method or another
method that could indicate the presence
of stx or eae genes or the presence of
one of the relevant ‘‘O’’ subgroups. Such
screen-positive results indicate the
presence of an organism capable of
causing illness. If an establishment does
not perform additional testing, it should
treat lots that test positive in screen tests
as positive. Similarly, FSIS will
consider those results positive for nonO157 STEC if not confirmed negative.
This is consistent with how FSIS
regards positive E. coli O157:H7 screen
results.
Therefore, if an establishment finds
product positive for any of the specified
non-O157 STECs in screen testing, does
not confirm the finding as negative, and
has not addressed the hazard in its
HACCP system, the establishment
would be required to take corrective
actions, including reassessing its
HACCP plan (9 CFR 417.3).
Comment: Commenters stated that a
large number of samples will screen
positive using the screening method
described in MLG 5B.01. Commenters
also stated that the isolation and
confirmation process takes a long time
to complete and that producers cannot
hold fresh product pending the
completion of isolation and
confirmation described in the MLG
5B.01.
Response: FSIS does not agree with
these assertions. Based on available
data, FSIS estimates that 2 percent of
PO 00000
Frm 00004
Fmt 4700
Sfmt 4700
raw beef samples tested using the FSIS
method would test positive for nonO157 STEC in screen tests, with a
significantly lower percentage being
confirmed. This is comparable to what
FSIS has found with the FSIS screening
method for E. coli O157:H7. The amount
of time to obtain a confirmation result
from the new FSIS non-O157 STEC
method is the same as that for the
current E. coli O157:H7 method. The
reagents for the FSIS test method,
including the confirmation method, are
commercially available to industry.
Establishment Testing
Comment: One commenter asked
whether, if an establishment only tested
for stx (Shiga toxin) and eae (intimin)
genes using a polymerase-chain-reaction
(PCR) screening test, and the sample
tested negative, FSIS would accept this
result as negative for E. coli O157:H7
and the specified non-O157 STECs.
Response: FSIS would accept as
negative for E. coli O157:H7 and the
specified non-O157 STECs a sample that
tests negative for eae and stx on a
screening test performed by an
establishment.
FSIS recognizes that industry uses
non-culture methods that detect
alternative target analytes for E. coli
O157:H7 including, but not limited to,
eae and stx. An establishment may
increase the likelihood of detecting all
hypothetical strains and low-levels of
contamination with these pathogens in
a variety of ways, including but not
limited to using a test method that is
also used by a regulatory body, or that
is validated and certified by an
independent body (e.g., AOAC
International, the French Association for
Standardization (AFNOR), the European
organization for the validation and
certification of alternative methods for
the microbiological analysis of food and
beverages (MicroVal), or the Nordic
system for validation of alternative
microbiological methods (NordVal)). An
establishment may also opt to use a test
method for detecting the specified
STECs that is subjected to a robust
validation using the FSIS cultural
method as a reference. In this case, a test
kit manufacturer may choose to ask the
Agency through AskFSIS to review the
method. If the method is found to be
adequate, FSIS will issue a NOL to the
test kit manufacturer for filing with the
establishment.
Comment: A law firm representing
beef industry clients asked whether,
during the transition period (until June
4, 2012), when establishments are ‘‘beta
testing’’ STEC analytical methods and
possibly refining their food safety
E:\FR\FM\31MYR1.SGM
31MYR1
Federal Register / Vol. 77, No. 105 / Thursday, May 31, 2012 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES1
system, a stage-one positive test result
would be considered positive.
Response: No, after the June 4
implementation date for the FSIS
verification testing program, positive
‘‘beta tests’’ will not be considered by
FSIS to be conclusive evidence that one
or more specified STECs is present in
the sample. However, if product from
the establishment is associated with a
non-O157 STEC outbreak, FSIS will take
steps to ensure that associated product
is removed from commerce and will
expect the establishment to take
corrective actions, including
reassessment of its HACCP plan, if
necessary, to prevent a recurrence of
this food safety hazard.
FSIS encourages establishments to
maintain records from ‘‘beta testing’’ as
part of the documentation of the
development of their food safety
systems. Establishments may use these
records to show the controls they have
in place and the disposition of their
products.
Comment: An industry commenter
asked where industry can obtain the
non-O157 STEC strains for testing
purposes.
Response: Non-O157 STEC strains
may be obtained from public
collections, including the STEC
collection at Michigan State University,
the E. coli Center at Penn State
University, the American Type Culture
Collection in Manassas, Virginia, and at
other locations.
Comment: One trade association
asked whether E. coli O157:H7 could be
used as both an indicator and an index
organism for non-O157 STEC in beef
production.
Response: If source materials are
sampled at a sufficiently high frequency
and in a consistent manner, test results
for the presence of E. coli O157:H7 or
non-O157 STEC can serve as indicators
of process control during beef
production. In fact, in data 3 from
inspection personnel at the top 33 (by
volume) beef slaughter establishments,
60 percent of establishments had
defined high-event periods when the
establishments could discern subtle
changes in the percent-positive
screening test results as evidence of a
process out of control. FSIS believes
that the screening tests that the industry
has been using are capable of indicating
3 To help develop the operational criteria for
industry to use to identify high-event periods and
for Enforcement, Investigations, and Analysis
Officers to consider when conducting traceback
procedures, FSIS examined industry data collected
by FSIS inspection personnel from the top 33
slaughter establishments, representing 80 percent of
industry production volume (number of cattle
slaughtered).
VerDate Mar<15>2010
16:27 May 30, 2012
Jkt 226001
the presence of more than just E. coli
O157:H7.
Because both E. coli O157:H7 and
non-O157 STECs occur in raw beef at
low levels and at low prevalence,
however, positive tests for these
pathogens are not likely to be highly
correlated. Therefore, neither E. coli
O157:H7 nor non-O157 STEC are
expected to provide reliable index
measurements. An index organism is
one whose concentration or frequency
correlates with the concentration or
frequency of another organism.
FSIS-Recommended Cooking
Temperatures
Comment: One commenter stated that
if STECs can survive ‘‘ordinary’’ or
‘‘typical’’ cooking, FSIS should
reconsider its cooking temperature
recommendations. Another commenter
stated that there is insufficient data
regarding heat tolerance of non-O157
STECs.
Response: FSIS’s temperature
recommendation for consumers to cook
ground beef to 160 degrees Fahrenheit is
adequate to achieve a safe product.
There is no reason to believe that a
higher temperature is necessary (https://
www.fsis.usda.gov/Fact_Sheets/
Ground_Beef_and_Food_Safety/
index.asp). However, FSIS is well aware
that some consumers ordinarily or
typically do not cook ground beef to 160
degrees Fahrenheit, in spite of the
extensive outreach and education efforts
conducted by the Agency and its public
health partners to change behaviors.4 In
addition, FSIS believes that most
consumers do not use a thermometer to
confirm the end-point temperature for
safety. Consequently, the handling and
preparation practices of many
consumers are not ‘‘ordinarily’’ or
‘‘typically’’ capable of rendering the
cooked ground beef safe without further
risk mitigation.
The September 20, 2011, Federal
Register notice cited the August 2010
STEC O26 outbreak and other evidence
(at 76 FR 58159—Luchansky et al.,
published in 74 J. Food Prot.
(2011)7:1054–1064) that demonstrates
that the strain survives ‘‘typical’’
cooking employed by some consumers,
and that further risk mitigation was
necessary. Researchers at USDA–ARS
examined the effect of various cooking
temperatures on strains of five
serogroups (O45, O103, O111, O121,
and O145) and E. coli O157:H7
inoculated into beef steaks that were
then tenderized. Results show that the
non-O157 STECs exhibited thermal
4 Ecosure. 2007 U.S. Cold Temperature
Evaluation. October 15, 2008.
PO 00000
Frm 00005
Fmt 4700
Sfmt 4700
31979
inactivation similar to that for E. coli
O157:H7.5 In another study (Duffy et al.,
2006), STEC O26 also showed similar
thermal tolerance to E. coli O157:H7.
Equivalency and Implementation
Concerns of Foreign Governments
Comment: Several commenters noted
that the September 20, 2011, Federal
Register notice states (at 76 FR 58161,
col. 1–2): ‘‘For imported products tested
at port of entry, if the product tests
positive at the second stage and has not
been held at the import establishment,
it will be subject to recall. If the product
has been held, the product will be
refused entry. As always, product
subsequently presented for import
inspection from the same foreign
country and establishment will be held
at the official import establishment
pending results.’’ These commenters
asked whether FSIS intended to treat
imported product tested for non-O157
STEC differently from such product
tested for E. coli O157:H7.
Several trade associations and foreign
governments addressed various topics
relating to the treatment of imported
products at port of entry, the
equivalency of foreign inspection
systems, and United States obligations
under World Trade Organization
agreements. Governments and industry
trade groups expressed concern that the
new non-O157 STEC policy may violate
the United States’ obligations under the
Agreement on Sanitary and
Phytosanitary (SPS) Measures. Finally,
governments and trade associations
questioned the adequacy of the FSIS
risk profile with respect to how it
addresses characteristics of non-O157
STEC.
Response: Consistent with FSIS’s
procedures for testing for E. coli
O157:H7 in imported product, if a
product offered for import tests positive
at port of entry for non-O157 STEC in
the screen test and has not been held at
the import establishment, it will not be
subject to recall. However, if the
product is still at the import
establishment, FSIS will retain the
product until it is confirmed negative.
If the product is confirmed positive
and has been held by the establishment
or retained by FSIS at the import
establishment, FSIS will refuse entry of
the product. If the confirmed-positive
product has not been held at the import
5 Luchansky J.B., Shoyer B.A., Call J., Schlosser
W., Shaw W., Bauer N., Latimer H., Porto-Fett A.
2012. Fate of Shiga-toxin producing O157:H7 and
non-O157:H7 Escherichia coli cells within bladetenderized beef steaks after cooking on a
commercial open-flame gas grill. Journal of Food
Protection. 75:62–70.
E:\FR\FM\31MYR1.SGM
31MYR1
mstockstill on DSK4VPTVN1PROD with RULES1
31980
Federal Register / Vol. 77, No. 105 / Thursday, May 31, 2012 / Rules and Regulations
establishment, FSIS will request that the
importer of record recall the product.
FSIS has notified its trading partners
about the new non-O157 STEC testing
policy. The Agency has committed to
video conferencing and teleconferencing
exchanges to assist foreign governments
in understanding the policy and how it
applies to them. The Agency expects
countries that export products to the
United States to address non-O157
STEC under existing agreements and to
prevent contamination of their raw beef
products with these adulterants. Foreign
countries may use any method that will
ensure, with reasonable confidence, that
products that they export to the United
States will not be contaminated with
detectable non-O157 STEC. Because of
the nature of non-O157 STECs, FSIS
would not exclude any country
importing product subject to testing
from non-O157 STEC verification
testing by FSIS.
Finally, the Agency has assessed
scientific data from several fields on the
risk posed by non-O157 STECs and
determined that these pathogens are
adulterants under the FMIA. To make
this determination, the Agency prepared
a risk profile, which has been
independently peer-reviewed in
accordance with Office of Management
and Budget (OMB) guidelines. Both CDC
and FDA reviewed the document and
supported FSIS’s approach.
The risk profile, in its final version,
incorporates CDC data that show that
the organisms for which FSIS will be
testing are known to cause more than 80
percent of human illnesses attributable
to non-O157 STECs in the United States.
In addition, FSIS refined the risk
profile substantially in response to
comments that were received during
peer review. Accordingly, the risk
profile represents the best
characterization of the science
associated with the risk from the
specified non-O157 STECs.
One commenter raised a concern
about the attribution of a non-O157
STEC outbreak in 2007 to a beef
product. This outbreak was included in
the risk profile.
CDC has information, including a May
21, 2010, memo, stating that, ‘‘The
preliminary data in the table were
obtained primarily from reports
voluntarily made by state health
departments to CDC. In 2010, we
supplemented NORS [National
Outbreak Reporting System] data from
the on non-O157 STEC outbreaks by
contacting state and federal health
agencies, by reviewing the scientific
literature, and by other methods.’’ The
data reported in the memo may be more
complete than the data submitted by the
VerDate Mar<15>2010
16:27 May 30, 2012
Jkt 226001
reporting agency to the Foodborne
Disease Outbreak Surveillance System
(FDOSS), which is a component of
NORS. In the memo, CDC listed the
confirmed or suspected vehicle for this
outbreak as ground beef. This was based
on a posting on the North Dakota State
Health Department Web site.
FSIS recognizes that the availability of
attribution data for the non-O157 STECs
is partially a function of the number of
clinical laboratories that test for the
pathogens, as well as of the robustness
of epidemiological investigations. In
this case, however, the only available
information suggests that the non-O157
STEC outbreak may have been linked to
a beef product.
Summary of Changes and Clarifications
Made in Response to Comments
As noted earlier in this document, in
response to comments on the September
20, 2011, notice (76 FR 58157), FSIS
extended the public comment period
from November 21, 2011, to December
21, 2011 (76 FR 72331; Nov. 23, 2011).
Also in response to public comments,
FSIS held a technical meeting December
1, 2011, to solicit additional comments.
FSIS later moved the implementation
date of the non-O157 STEC verification
policy for beef manufacturing trimmings
to June 4, 2012 (77 FR 9888; Feb. 21,
2012). The purpose of the delay in
implementation was to allow the
regulated establishments time to effect
any necessary changes in their food
safety systems, including process
control procedures, and to allow time
for improvements in testing methods.
In addition, in response to comments,
the Agency made available to foreign
governments reagents used in the FSIS
method. To allay other concerns of
foreign governments, the Agency
affirmed that it would treat incoming
foreign product in the same way that it
treats such product FSIS tests for E. coli
O157:H7.
On the matter of using indicator
organisms, FSIS has affirmed that
testing of source materials of raw, nonintact beef products for STEC to verify
process controls can be effective if the
materials are sampled at sufficiently
high frequencies. However, FSIS has
clarified that E. coli O157:H7 is not an
index organism for non-O157 STEC.
In response to questions, FSIS has
clarified that establishments are not
required to take corrective actions in
response to FSIS screen positive results.
However, FSIS has also clarified that if
establishments find product positive for
non-O157 STECs in their screen tests
and do not conduct further testing to
confirm that the product is negative,
FSIS will consider the product positive
PO 00000
Frm 00006
Fmt 4700
Sfmt 4700
for non-O157 STECs, just as FSIS
considers product that screens positive
for E. coli O157:H7 to be positive if an
establishment does not conduct further
testing.
Finally, the Agency has finalized the
risk profile on the non-O157 STECs and
has incorporated relevant information
conveyed by commenters.
Executive Order 13175
The policy discussed in this notice
does not have Tribal Implications that
preempt Tribal Law.
USDA Nondiscrimination Statement
The U.S. Department of Agriculture
(USDA) prohibits discrimination in all
its programs and activities on the basis
of race, color, national origin, gender,
religion, age, disability, political beliefs,
sexual orientation, and marital or family
status. (Not all prohibited bases apply to
all programs.) Persons with disabilities
who require alternative means for
communication of program information
(Braille, large print, audiotape, etc.)
should contact USDA’s Target Center at
202–720–2600 (voice and TTY).
To file a written complaint of
discrimination, write USDA, Office of
the Assistant Secretary for Civil Rights,
1400 Independence Avenue SW.,
Washington, DC 20250–9410 or call
202–720–5964 (voice and TTY). USDA
is an equal opportunity provider and
employer.
Additional Public Notification
Public awareness of all segments of
rulemaking and policy development is
important. Consequently, FSIS will
announce it on-line through the FSIS
Web page located at—https://www.fsis.
usda.gov/regulations_&_policies/
Interim_&_Final_Rules/index.asp.
FSIS also will make copies of this
Federal Register publication available
through the FSIS Constituent Update,
which is used to provide information
regarding FSIS policies, procedures,
regulations, Federal Register notices,
FSIS public meetings, and other types of
information that could affect or would
be of interest to our constituents and
stakeholders. The Update is
communicated via Listserv, a free email
subscription service consisting of
industry, trade, and farm groups,
consumer interest groups, allied health
professionals, scientific professionals,
and other individuals who have
requested to be included. The Update
also is available on the FSIS Web page.
Through Listserv and the Web page,
FSIS is able to provide information to a
much broader, more diverse audience.
In addition, FSIS offers an email
subscription service which provides
E:\FR\FM\31MYR1.SGM
31MYR1
Federal Register / Vol. 77, No. 105 / Thursday, May 31, 2012 / Rules and Regulations
automatic and customized access to
selected food safety news and
information. This service is available at
https://www.fsis.usda.gov/News_&_
Events/Email_Subscription/. Options
range from recalls, export information,
regulations, directives, and notices.
Customers can add or delete
subscriptions themselves, and have the
option to password-protect their
accounts.
Done at Washington, DC, May 25, 2012.
Alfred V. Almanza,
Administrator.
[FR Doc. 2012–13283 Filed 5–29–12; 4:15 pm]
BILLING CODE 3410–DM–P
NATIONAL CREDIT UNION
ADMINISTRATION
12 CFR Parts 701, 703, 713, 721, 723,
and 742
RIN 3133–AD98
Eligible Obligations, Charitable
Contributions, Nonmember Deposits,
Fixed Assets, Investments, Fidelity
Bonds, Incidental Powers, Member
Business Loans, and Regulatory
Flexibility Program
National Credit Union
Administration (NCUA).
ACTION: Final rule and interim final rule
with comment period.
AGENCY:
NCUA is removing certain
regulations and eliminating the
Regulatory Flexibility Program
(RegFlex) to provide regulatory relief to
federal credit unions. NCUA is also
removing or amending related rules to
ease compliance burden while retaining
certain safety and soundness standards.
Those rules pertain to eligible
obligations, charitable contributions,
nonmember deposits, fixed assets,
investments, incidental powers, and
member business loans. In addition,
NCUA is issuing an interim final rule
with a request for comment to amend a
provision in the fidelity bond rule to
remove references to RegFlex.
DATES: Effective dates: The final rule, as
well as the interim final rule pertaining
to the revisions in the fidelity bond rule,
§ 713.6, will go into effect on July 2,
2012.
Comment date: We will consider
comments on the interim final rule
portion (the fidelity bond rule, § 713.6),
as discussed in section IV of the
preamble of this rulemaking. Send your
comments to reach us on or before July
30, 2012. We may not consider
comments received after the above date
mstockstill on DSK4VPTVN1PROD with RULES1
SUMMARY:
VerDate Mar<15>2010
16:27 May 30, 2012
Jkt 226001
in making any decision whether to
amend the interim final rule.
ADDRESSES: In commenting on the
interim final rule, you may submit
comments by any of the following
methods (Please send comments by one
method only):
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• NCUA Web Site: https://www.ncua.
gov/Legal/Regs/Pages/PropRegs.aspx.
Follow the instructions for submitting
comments.
• Email: Address to
regcomments@ncua.gov. Include ‘‘[Your
name] Comments on Interim Final Rule,
Section 713.6, Fidelity Bond’’ in the
email subject line.
• Fax: (703) 518–6319. Use the
subject line described above for email.
• Mail: Address to Mary Rupp,
Secretary of the Board, National Credit
Union Administration, 1775 Duke
Street, Alexandria, Virginia 22314–
3428.
• Hand Delivery/Courier: Same as
mail address.
Public Inspection: You can view all
public comments on NCUA’s Web site
at https://www.ncua.gov/Legal/Regs/
Pages/PropRegs.aspx as submitted,
except for those we cannot post for
technical reasons. NCUA will not edit or
remove any identifying or contact
information from the public comments
submitted. You may inspect paper
copies of comments in NCUA’s law
library at 1775 Duke Street, Alexandria,
Virginia 22314, by appointment
weekdays between 9 a.m. and 3 p.m. To
make an appointment, call (703) 518–
6546 or send an email to
OGCMail@ncua.gov.
FOR FURTHER INFORMATION CONTACT:
Chrisanthy Loizos, Staff Attorney, Office
of General Counsel, at the above address
or telephone (703) 518–6540, or
Matthew J. Biliouris, Director of
Supervision, or J. Owen Cole, Director,
Division of Capital Markets, Office of
Examination and Insurance, at the above
address or telephone (703) 518–6360.
SUPPLEMENTARY INFORMATION:
I. Background
II. Summary of Comments on December 2011
Proposed Rule
III. Final Rule
IV. Interim Final Rule and Request for
Comment
V. Rule Summary Table
VI. Regulatory Procedures
I. Background
a. Why is NCUA adopting this rule?
On July 11, 2011, President Obama
issued Executive Order 13579, ordering
independent agencies, including NCUA,
PO 00000
Frm 00007
Fmt 4700
Sfmt 4700
31981
to consider whether they can modify,
streamline, expand, or repeal existing
rules to make their programs more
effective and less burdensome.
Consistent with the spirit of the
Executive Order and as part of NCUA’s
Regulatory Modernization Initiative, the
NCUA Board (Board) is adopting this
rule to streamline its regulatory program
by eliminating RegFlex. The final rule
relieves regulatory burden on federal
credit unions (FCUs) because they will
no longer need to engage in any process
for a RegFlex designation. In addition,
the final rule provides regulatory relief
to FCUs that are currently not RegFlex
eligible because it extends to them most
of the flexibilities previously available
only to RegFlex FCUs.
The Board issued a Notice of
Proposed Rulemaking (NPRM) in
December 2011. 76 FR 81421 (Dec. 28,
2011). The comment period on the
proposed rule ended on February 27,
2012. NCUA received seventeen
comment letters on the NPRM: Four
from FCUs, three from trade
associations (1 representing banks, 2
representing credit unions), nine from
state credit union leagues, and one from
a law firm. The majority of the
commenters supported the rulemaking
generally. Four commenters did not
support the rule as proposed, and the
remaining commenters offered
comments on particular provisions but
did not take a position on the initiative
as a whole. For the reasons discussed
below, the Board is adopting the
amendments almost exactly as
proposed. As such, the Board does not
restate the legal analysis it presented in
the NPRM’s preamble and incorporates
it by reference here in this rulemaking.
Id.
b. What was RegFlex?
The Board established RegFlex in
2002. 66 FR 58656 (Nov. 23, 2001).
RegFlex relieved FCUs from certain
regulatory restrictions and granted them
additional powers if they demonstrated
sustained superior performance as
measured by CAMEL rating and net
worth classification. An FCU could
qualify for RegFlex treatment
automatically or by application to the
appropriate regional director.
Specifically, an FCU automatically
qualified for a RegFlex designation
when it received a composite CAMEL
rating of ‘‘1’’ or ‘‘2’’ for two consecutive
examination cycles and maintained a
net worth classification of ‘‘well
capitalized’’ under part 702 of NCUA’s
rules for the last six quarters. An FCU
subject to a risk-based net worth
(RBNW) requirement under part 702
could also qualify for RegFlex treatment
E:\FR\FM\31MYR1.SGM
31MYR1
Agencies
[Federal Register Volume 77, Number 105 (Thursday, May 31, 2012)]
[Rules and Regulations]
[Pages 31975-31981]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-13283]
========================================================================
Rules and Regulations
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains regulatory documents
having general applicability and legal effect, most of which are keyed
to and codified in the Code of Federal Regulations, which is published
under 50 titles pursuant to 44 U.S.C. 1510.
The Code of Federal Regulations is sold by the Superintendent of Documents.
Prices of new books are listed in the first FEDERAL REGISTER issue of each
week.
========================================================================
Federal Register / Vol. 77, No. 105 / Thursday, May 31, 2012 / Rules
and Regulations
[[Page 31975]]
DEPARTMENT OF AGRICULTURE
Food Safety and Inspection Service
9 CFR Parts 416, 417, and 430
[Docket No. FSIS-2010-0023]
Shiga Toxin-Producing Escherichia coli in Certain Raw Beef
Products
AGENCY: Food Safety and Inspection Service, USDA.
ACTION: Response to comments on final determination; planned
implementation for testing raw beef manufacturing trimmings.
-----------------------------------------------------------------------
SUMMARY: The Food Safety and Inspection Service (FSIS) is confirming
that it will implement routine verification testing for six Shiga
toxin-producing Escherichia coli (STEC), in addition to E. coli
O157:H7, in raw beef manufacturing trimmings beginning June 4, 2012.
FSIS is also responding to comments on the final determination
published September 20, 2011, in the Federal Register regarding the
June 4, 2012, implementation of STEC sampling and related issues.
DATES: Beginning June 4, 2012, FSIS will implement routine verification
testing for the six additional STECs discussed in this document (O26,
O45, O103, O111, O121, and O145), in raw beef manufacturing trimmings
(domestic or imported) derived from cattle slaughtered on or after June
4, 2012. To allow industry time to implement any appropriate changes in
food safety systems, including control procedures in their processes,
FSIS will generally not regard raw, non-intact beef products or the
components of these products found to have these pathogens as
adulterated until June 4, 2012. FSIS will announce in a future Federal
Register document the date it intends to implement routine verification
testing for the specified STECs in additional raw beef products tested
by FSIS for E. coli O157:H7, including ground beef.
FOR FURTHER INFORMATION CONTACT: Rachel Edelstein, Acting Assistant
Administrator, Office of Policy and Program Development, Food Safety
and Inspection Service, U.S. Department of Agriculture, (202) 205-0495.
SUPPLEMENTARY INFORMATION:
Background
On September 20, 2011, FSIS published a document in the Federal
Register announcing its determination that raw, non-intact beef
products, or raw, intact beef products that are intended for use in raw
non-intact product, that are contaminated with Shiga toxin-producing
Escherichia coli (STEC) O26, O45, O103, O111, O121, and O145 are
adulterated within the meaning of 21 U.S.C. 601(m)(1) (76 FR 58157;
Sep. 20, 2011). The products are adulterated because they contain a
poisonous or deleterious substance that may render them injurious to
health. FSIS stated that raw, non-intact beef products that are
contaminated with these STEC are also unhealthful and unwholesome
(under 21 U.S.C. 601(m)(1) and (m)(3)) (76 FR 58157 at 76 FR 58159).
FSIS also considers intact cuts that are contaminated with these
pathogens to be adulterated, unhealthful, and unfit for human food if
they are to be further processed into raw, non-intact products before
being distributed for consumption (76 FR 58157 at 76 FR 58159).
FSIS announced that it intended to implement sampling and testing
for the six non-O157 STEC, as it already does for E. coli O157:H7. The
Agency said that it would begin this verification and testing program
on March 5, 2012. The Agency noted that it would initially sample only
raw beef manufacturing trimmings and other ground beef components for
the six non-O157 STEC, but that it would consider other products,
including raw ground beef contaminated with these STEC, to be
adulterated (at 76 FR 58160). The Agency asked for comments on its
plans for implementing the program (at 76 FR 58157, 58164).
In addition, FSIS asked for comments on Agency plans for a baseline
survey of the prevalence of the specified STEC in raw beef products,
whether to hold technical or other public meetings, various cost
estimates, the type of outreach and information that would be most
useful to establishments preparing for implementation by the Agency of
its sampling and verification testing program, and information that
foreign governments might need to address inspection equivalency or
implementation concerns.
FSIS extended the public comment period from November 21, 2011, to
December 21, 2011, and held a public meeting by teleconference on
December 1, 2011. (76 FR 72331; Nov. 23, 2011).
In response to comments received from industry, FSIS issued a
Federal Register notice (77 FR 9888; Feb. 21, 2012) in which FSIS moved
the implementation date to June 4, 2012, for routine verification
activities, including testing, for the six specified STEC in raw beef
manufacturing trimmings derived from cattle slaughtered on or after
June 4, 2012. To allow establishments time to implement appropriate
changes in their food safety systems, including changes in process
control procedures, FSIS will generally not treat as adulterated raw
beef products found to have these pathogens until June 4, 2012.
Additionally, FSIS will begin conducting for-cause food safety
assessments (FSAs) in response to FSIS positive non-O157 STEC results
approximately 90 days after FSIS implements non-O157 STEC sampling and
testing in beef manufacturing trimmings. This 90-day period will
provide establishments sufficient time to make any necessary changes to
their food safety systems.
When FSIS laboratories analyze the samples, FSIS anticipates that
there will be some samples that will, in the first stage of the FSIS
screen test, test positive for Shiga toxin gene (stx) and for the
intimin gene (eae) but screen negative for all the target O-groups
(O26, O45, O103, O111, O121, and O145). Such samples will be referred
to the USDA-Agricultural Research Service (ARS) for further
microbiological analysis to determine whether they are positive for
other target O-groups. FSIS expects to collect and analyze these screen
results from its verification tests for at least the first year of
testing. FSIS will not consider the product associated with non-
confirmed results to be adulterated. FSIS believes that the information
on these screen results will be useful to establishments in enhancing
the preventive controls in
[[Page 31976]]
their food safety systems and believes that establishments will benefit
from knowing whether they have screen-positive but not confirmed sample
results for E. coli O157:H7 or the specified non-O157 STECs. Therefore,
FSIS is contemplating providing individual establishments with this
information every quarter. In addition, FSIS expects to regularly make
aggregate information known to stakeholders in order for stakeholders
to be aware of and to consider the relevance of the information.
FSIS, as a public health regulatory agency, has adopted a
preventive, risk mitigation strategy that takes into consideration the
fact that the specified STECs are adulterants of certain raw beef
products. In support of this strategy, FSIS has finalized its risk
profile to reflect comments, the results in a recent article on thermal
resistance of STEC-inoculated non-intact beef steaks with strains of E.
coli O157:H7 and non-O157 STEC (a pooled composite of STEC serogroups
O45, O103, O111, O121, and O145) by USDA-ARS (Luchansky et al., 2012),
and information from articles on how much more common non-O157 STEC
infections are compared to E. coli O157:H7 infections (Blanco et al.,
2004; Elliott et al., 2001; Nielsen et al., 2006; Vally et al., 2012).
The final risk profile is available on the FSIS Web site at https://www.fsis.usda.gov/Science/Risk_Assessments/index.asp
In the September 20, 2011, Federal Register, FSIS also announced
the availability of, and requested comments on, the guidance document,
Validation Guidance for Pathogen Detection Test Kits. FSIS explained
that the Agency prepared this guidance for the validation of test kits
for the detection of pathogens, including both E. coli O157:H7 and non-
O157 STEC. FSIS encouraged organizations that design or conduct
validation studies to avail themselves of this guidance document in
meeting the pertinent regulatory requirements. FSIS received numerous
comments on this document, will update it as necessary in response to
comments, and will announce the availability of the updated guidance
document when it is ready.
I. Implementation plan
In finalizing the plan for implementing its verification
activities, including the sampling and testing program for the
specified STECs, FSIS considered all comments submitted in response to
the September 2011 final determination, as well as comments provided at
the December 1 teleconference, and is clarifying certain aspects of the
implementation of the verification activities.
FSIS will issue a Federal Register notice announcing when FSIS will
begin routine sampling and testing for the seven STECs of all raw beef
products subject to Agency E. coli O157:H7 sampling and testing, from
both domestic and international sources, regardless of the slaughter
date of cattle from which the product is derived. When expanded testing
begins, mixtures of raw beef derived from cattle slaughtered either
before or after June 4, 2012, whether the production lot contains raw
beef manufacturing trimmings, other raw ground beef components, bench
trim, or ground beef, will be subject to testing for the seven
specified STECs.
The Agency is updating the economic analysis published in the
September 20, 2011, Federal Register notice in response to public
comments received. To respond more thoroughly to the comments, FSIS
will incorporate any additional data on establishment and Agency
testing for the specified STECs that may be available upon FSIS's
implementation of routine testing for non-O157 STECs in beef
manufacturing trimmings. As indicated in the September 20 notice (at 76
FR 58163), the Agency will update and revise the September 20, 2011,
economic analysis, will respond to comments received on the earlier
analysis, and will assess the economic effects of testing for the
specified STECs on raw beef manufacturing trimmings, other raw ground
beef components, and ground beef. When the Agency completes the updated
analysis, FSIS will announce its availability and request comments on
the analysis. The Agency will then assess comments and make any
necessary changes before finalizing the economic analysis and before
expanding FSIS testing to include other raw ground beef components and
ground product.
II. Comments and Responses
FSIS received approximately 34 comments in response to the
September 2011 notice. Comments received from consumer groups supported
the implementation of the final determination that six additional STEC
serotypes are considered adulterants in non-intact raw beef products
and intact beef products used to produce such products and encouraged
FSIS to resist delaying the implementation date. Several consumer
advocacy groups, citing the incidence of foodborne disease caused by
these organisms, expressed support for FSIS's final determination.
Comments submitted by industry, trade associations, and foreign
countries expressed concerns about the final determination and
implementation of the verification sampling and testing program.
Following is a discussion of comments that requested more
information or clarification regarding the verification testing program
that will begin on June 4, 2012.
Delay Implementation
Comment: Many commenters requested a delay of the implementation
date for the testing of the specified STECs for various reasons,
including their view that FSIS needs to conduct a baseline of non-O157
STECs on beef products, needs to wait until commercially available test
kits for these organisms become available and can be validated, needs
to hold a technical meeting, and needs to conduct a risk assessment.
Response: FSIS has concluded that a baseline is neither necessary
nor warranted before implementation of the FSIS verification sampling
and testing program. These organisms are present in beef products in
the United States; the evidence for this is presented in the risk
profile. FSIS considers the data on non-O157 STECs obtained by the
Agricultural Research Service (ARS) at a limited number of slaughter
establishments to be evidence that the pathogens should be considered
adulterants and are capable of causing illness. FSIS also considered
data collected by the person who petitioned the Agency to declare these
pathogens to be adulterants in a limited geographical retail area. The
Agency has concluded, on the basis of information in a report from the
Centers for Disease Control and Prevention (CDC), that these organisms
pose a significant public health burden in the United States.\1\ FSIS
and the CDC believe that there are more unreported and unconfirmed
illnesses associated with the specified non-O157 STECs than with E.
coli O157:H7.
---------------------------------------------------------------------------
\1\ Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A,
Roy SL, Jones JL, and Griffin PM. 2011. Foodborne illness acquired
in the United States--major pathogens. Emerg Infect Dis.
---------------------------------------------------------------------------
Nonetheless, in 2013 FSIS intends to conduct the carcass baseline
survey discussed in the September 20, 2011 Federal Register notice.
This microbiological survey will analyze samples from carcasses for the
presence of the pathogens E. coli O157:H7 and the specified STECs,
Salmonella, and indicator bacteria (generic E. coli, coliforms, and
Enterobacteriaceae). This baseline will be designed to identify the
type, level, and frequency of
[[Page 31977]]
contamination of carcasses immediately after hide removal but before
decontamination treatments and evisceration. When the baseline study is
being developed, FSIS will share the study design with stakeholders.
Regarding a baseline for raw beef manufacturing trimmings, other
raw ground beef components, and ground beef, FSIS is assessing its
current verification testing programs to see how those programs can be
modified to yield on-going baseline information and obviate the need
for stand-alone baseline studies.
At this time, FSIS is not planning to host a technical meeting
relating to non-O157 STEC. Commenters did not identify any specific
need for a technical meeting. If there is evidence that a technical
meeting would be helpful to industry, FSIS will, of course, reconsider
this issue.
Screening and confirmation methods for non-O157 STEC are available
to industry. In addition, reagents are commercially available to those
companies planning to use the FSIS method. Some establishments have
been testing for non-O157 STECs for a year or more.
Several companies have submitted test kits to detect at least the
six specified STEC O-groups for review by validation bodies. Using the
FSIS compliance guidelines related to validating test kits, FSIS has
reviewed validation data from test kits and issued no-objection-letters
(NOLs) to several manufacturers. The NOLs provide establishments with
supporting documentation regarding the reliability of verification
testing results. Confirmation testing is available to industry through
commercial reagents.
Regarding the contention that a risk assessment is needed, the
Agency has assessed scientific data from several fields on the risk
posed by non-O157 STECs and determined that these pathogens are
adulterants under the FMIA. To make this determination, the Agency
prepared a risk profile, which has been independently peer reviewed in
accordance with Office of Management and Budget (OMB) guidelines. Both,
the CDC and the Food and Drug Administration (FDA)/Center for Food
Safety and Applied Nutrition reviewed the document and provided input
on FSIS' approach. The risk profile lays out all available information
on the public health concerns posed by these organisms and supports the
adulteration determination regarding these E. coli serogroups.
FSIS Sampling Plan
Comment: Several commenters stated that FSIS has not adequately
justified the initiation of the non-O157 STEC sampling program, given
that non-O157 STECs are found at levels comparable to E. coli O157:H7,
and infection from the non-O157 STEC tends to be less severe than that
from E. coli O157:H7. One commenter questioned whether FSIS's testing
program will be adequate for determining process control and stated
that FSIS's end-product testing will have no impact other than to
consume resources that could be better spent on food safety research.
Response: The FSIS verification testing program is intended to
assess whether the industry, collectively, is controlling for the
presence of a designated food safety hazard in products regulated by
FSIS. Adding the six non-O157 STECs to the group of pathogens for which
FSIS tests will help in improving food safety. The purpose of the new
testing program for non-O157 STECs is to verify that establishments
producing raw beef products have adequately addressed these pathogens.
FSIS acknowledges that the best approach to reducing STEC
contamination lies not in comprehensive end-product testing but in the
development and implementation of science-based preventive controls,
with end-product testing to verify process control. FSIS's non-O157
STEC testing program will improve food safety because FSIS anticipates
that establishments may voluntarily make changes to their food safety
systems in response to the new testing. For example, establishments may
initiate a testing program for non-O157 STECs or may add new
interventions to address pathogens. FSIS is aware that some companies
have added new bacteriophage interventions to address non-O157 STEC.
FSIS is not requiring such changes but anticipates establishments may
make these types of changes in response to the testing.
The non-O157 STECs may cause illnesses of varying severity. Though
limited data are available on dose-response, there is evidence that the
infectious doses of the pathogens are relatively low. Hence, their
potential to cause illness is relatively high. Although there is
variability in virulence severity of non-O157 STECs, the six specified
non-O157 STEC organisms can cause severe foodborne illness requiring
hospitalization. Numerous illnesses in the United States have resulted
from all six of the non-O157 STECs. CDC data show that the six STEC
organisms for which FSIS will be testing are known to cause more than
80 percent of human illnesses attributed to non-O157 STEC.
The number of illnesses and deaths caused by non-O157 STECs and
associated with beef consumption or a beef source is likely to decline
if establishments voluntarily make changes to their food safety system
that result in greater public health protection. Also, FSIS's current
testing for E. coli O157:H7 may not detect other STECs that may be
present in the product.
Comment: One industry commenter asked whether FSIS intends to
collect two samples for N-60 sampling, and if so, would E. coli O157:H7
testing be performed on one sample and non-O157 STEC testing on the
other sample. Another commenter noted that FSIS does not specify the
number of samples it intends to collect in the sampling plan.
Response: FSIS inspection personnel will collect one N-60 sample
(in multiple containers) that will be tested for all the STECs,
including E. coli O157:H7. Eventually, FSIS will analyze all the raw
beef samples collected for both E. coli O157:H7 and non-O157 STEC.
Comment: Several commenters stated that FSIS's sampling plan should
be designed to estimate prevalence of the STEC pathogens in raw beef
products.
Response: FSIS verification testing programs are not designed at
this time to assess statistically-based national prevalence for select
organisms. FSIS verification testing assesses establishment control of
a food safety hazard in products regulated by FSIS. The number of tests
FSIS will annually conduct for non-O157 STECs will exceed the number
typically analyzed in a structured baseline. Although FSIS's testing
will not provide a true prevalence estimate upon implementation, it
will provide helpful information about whether establishments' food
safety systems adequately address food safety.
Comment: One commenter asked how FSIS intends to increase its
collection rates for its beef manufacturing trimmings testing program.
Response: The Agency has a number of different initiatives underway
to increase its collection rates for the beef manufacturing trimmings
testing programs. Importantly, the new Public Health Information System
(PHIS), which is now implemented nationwide, can schedule samples for
laboratory analysis. PHIS does so in a way that ensures that requests
are sent only to establishments whose profiles (information on
establishment
[[Page 31978]]
characteristics) indicate that they are producing the targeted product
at the time of sample scheduling. In addition, if an establishment no
longer makes the product, PHIS allows inspection program personnel to
modify the establishment profile (information on establishment
characteristics) to reflect this change so that future samples are not
scheduled for that establishment.
FSIS Testing Method
Comment: One association questioned whether the FSIS method
published in the Microbiology Laboratory Guidebook (MLG) on November 4,
2011, was appropriately peer-reviewed. Commenters questioned whether
industry is required to test for non-O157 STECs, and whether industry
would be required to use the FSIS method.
Response: Initial results from the method-development phase were
published in a peer-reviewed journal with ARS and FSIS authors.\2\ The
MLG method was validated and then verified for internal use by FSIS
Laboratory Services. In addition, when designing the screening and
confirmatory strategy for the regulatory test, FSIS sought input from
the CDC, ARS, and the FDA and worked closely with ARS in transferring
the method to use in the FSIS laboratories.
---------------------------------------------------------------------------
\2\ Fratamico, P.M., Bagi, L.K., Cray Jr, W.C., Narang, N.,
Medina, M.B., Liu, Y. Detection by multiplex real-time PCR assays
and isolation of Shiga toxin-producing Escherichia coli serogroups
O26, O45, O103, O111, O121, and O145 in ground beef. Foodborne
Pathogens and Disease 2011; 8(5):601-7.
---------------------------------------------------------------------------
FSIS is not requiring STEC testing by industry, nor will it
establish a requirement for the FSIS testing methodology to be used.
Also, foreign government central competent authorities and foreign
establishments can determine what testing to conduct and can use any
test that they determine is sufficient to identify the presence of the
specified STECs. As with the domestic beef establishments, foreign
government central competent authorities and foreign establishments are
expected to ensure that raw beef product is controlled for the presence
of the specified non-O157 STECs.
Comment: One commenter asked whether the most-probable-number (MPN)
enumeration was included in the FSIS method.
Response: No, the FSIS MLG method 5B.01 as described does not
include an MPN method for enumerating non-O157 STEC in positive
samples.
Comment: Several commenters questioned the Agency's statement
referring to expected establishment actions following stx- or eae-
positive first-stage screen results (at 76 FR 58161, col. 3): ``A
first-stage screen positive (stx and eae) is evidence of the presence
of Shiga toxin and intimin and may indicate that an establishment is
not adequately addressing hazards reasonably likely to occur.
Establishments should reassess their HACCP plans, Sanitation Standard
Operating Procedures, or other prerequisite programs on the basis of
this evidence.'' Commenters were concerned that an establishment would
be required to reassess its Hazard Analysis and Critical Control Point
(HACCP) plan after such results.
Response: The Agency regrets any confusion that this statement
created. The first- and second-stage screening steps of the FSIS method
are performed concurrently, not sequentially. Establishments are not
required to take corrective actions or reassess their HACCP plans in
response to positive FSIS screen results. However, establishments would
be required to take corrective actions or reassess their HACCP plans in
response to FSIS confirmed positive results for the specified non-O157
STEC.
Some establishments may use the FSIS laboratory method or another
method that could indicate the presence of stx or eae genes or the
presence of one of the relevant ``O'' subgroups. Such screen-positive
results indicate the presence of an organism capable of causing
illness. If an establishment does not perform additional testing, it
should treat lots that test positive in screen tests as positive.
Similarly, FSIS will consider those results positive for non-O157 STEC
if not confirmed negative. This is consistent with how FSIS regards
positive E. coli O157:H7 screen results.
Therefore, if an establishment finds product positive for any of
the specified non-O157 STECs in screen testing, does not confirm the
finding as negative, and has not addressed the hazard in its HACCP
system, the establishment would be required to take corrective actions,
including reassessing its HACCP plan (9 CFR 417.3).
Comment: Commenters stated that a large number of samples will
screen positive using the screening method described in MLG 5B.01.
Commenters also stated that the isolation and confirmation process
takes a long time to complete and that producers cannot hold fresh
product pending the completion of isolation and confirmation described
in the MLG 5B.01.
Response: FSIS does not agree with these assertions. Based on
available data, FSIS estimates that 2 percent of raw beef samples
tested using the FSIS method would test positive for non-O157 STEC in
screen tests, with a significantly lower percentage being confirmed.
This is comparable to what FSIS has found with the FSIS screening
method for E. coli O157:H7. The amount of time to obtain a confirmation
result from the new FSIS non-O157 STEC method is the same as that for
the current E. coli O157:H7 method. The reagents for the FSIS test
method, including the confirmation method, are commercially available
to industry.
Establishment Testing
Comment: One commenter asked whether, if an establishment only
tested for stx (Shiga toxin) and eae (intimin) genes using a
polymerase-chain-reaction (PCR) screening test, and the sample tested
negative, FSIS would accept this result as negative for E. coli O157:H7
and the specified non-O157 STECs.
Response: FSIS would accept as negative for E. coli O157:H7 and the
specified non-O157 STECs a sample that tests negative for eae and stx
on a screening test performed by an establishment.
FSIS recognizes that industry uses non-culture methods that detect
alternative target analytes for E. coli O157:H7 including, but not
limited to, eae and stx. An establishment may increase the likelihood
of detecting all hypothetical strains and low-levels of contamination
with these pathogens in a variety of ways, including but not limited to
using a test method that is also used by a regulatory body, or that is
validated and certified by an independent body (e.g., AOAC
International, the French Association for Standardization (AFNOR), the
European organization for the validation and certification of
alternative methods for the microbiological analysis of food and
beverages (MicroVal), or the Nordic system for validation of
alternative microbiological methods (NordVal)). An establishment may
also opt to use a test method for detecting the specified STECs that is
subjected to a robust validation using the FSIS cultural method as a
reference. In this case, a test kit manufacturer may choose to ask the
Agency through AskFSIS to review the method. If the method is found to
be adequate, FSIS will issue a NOL to the test kit manufacturer for
filing with the establishment.
Comment: A law firm representing beef industry clients asked
whether, during the transition period (until June 4, 2012), when
establishments are ``beta testing'' STEC analytical methods and
possibly refining their food safety
[[Page 31979]]
system, a stage-one positive test result would be considered positive.
Response: No, after the June 4 implementation date for the FSIS
verification testing program, positive ``beta tests'' will not be
considered by FSIS to be conclusive evidence that one or more specified
STECs is present in the sample. However, if product from the
establishment is associated with a non-O157 STEC outbreak, FSIS will
take steps to ensure that associated product is removed from commerce
and will expect the establishment to take corrective actions, including
reassessment of its HACCP plan, if necessary, to prevent a recurrence
of this food safety hazard.
FSIS encourages establishments to maintain records from ``beta
testing'' as part of the documentation of the development of their food
safety systems. Establishments may use these records to show the
controls they have in place and the disposition of their products.
Comment: An industry commenter asked where industry can obtain the
non-O157 STEC strains for testing purposes.
Response: Non-O157 STEC strains may be obtained from public
collections, including the STEC collection at Michigan State
University, the E. coli Center at Penn State University, the American
Type Culture Collection in Manassas, Virginia, and at other locations.
Comment: One trade association asked whether E. coli O157:H7 could
be used as both an indicator and an index organism for non-O157 STEC in
beef production.
Response: If source materials are sampled at a sufficiently high
frequency and in a consistent manner, test results for the presence of
E. coli O157:H7 or non-O157 STEC can serve as indicators of process
control during beef production. In fact, in data \3\ from inspection
personnel at the top 33 (by volume) beef slaughter establishments, 60
percent of establishments had defined high-event periods when the
establishments could discern subtle changes in the percent-positive
screening test results as evidence of a process out of control. FSIS
believes that the screening tests that the industry has been using are
capable of indicating the presence of more than just E. coli O157:H7.
---------------------------------------------------------------------------
\3\ To help develop the operational criteria for industry to use
to identify high-event periods and for Enforcement, Investigations,
and Analysis Officers to consider when conducting traceback
procedures, FSIS examined industry data collected by FSIS inspection
personnel from the top 33 slaughter establishments, representing 80
percent of industry production volume (number of cattle
slaughtered).
---------------------------------------------------------------------------
Because both E. coli O157:H7 and non-O157 STECs occur in raw beef
at low levels and at low prevalence, however, positive tests for these
pathogens are not likely to be highly correlated. Therefore, neither E.
coli O157:H7 nor non-O157 STEC are expected to provide reliable index
measurements. An index organism is one whose concentration or frequency
correlates with the concentration or frequency of another organism.
FSIS-Recommended Cooking Temperatures
Comment: One commenter stated that if STECs can survive
``ordinary'' or ``typical'' cooking, FSIS should reconsider its cooking
temperature recommendations. Another commenter stated that there is
insufficient data regarding heat tolerance of non-O157 STECs.
Response: FSIS's temperature recommendation for consumers to cook
ground beef to 160 degrees Fahrenheit is adequate to achieve a safe
product. There is no reason to believe that a higher temperature is
necessary (https://www.fsis.usda.gov/Fact_Sheets/Ground_Beef_and_Food_Safety/index.asp). However, FSIS is well aware that some
consumers ordinarily or typically do not cook ground beef to 160
degrees Fahrenheit, in spite of the extensive outreach and education
efforts conducted by the Agency and its public health partners to
change behaviors.\4\ In addition, FSIS believes that most consumers do
not use a thermometer to confirm the end-point temperature for safety.
Consequently, the handling and preparation practices of many consumers
are not ``ordinarily'' or ``typically'' capable of rendering the cooked
ground beef safe without further risk mitigation.
---------------------------------------------------------------------------
\4\ Ecosure. 2007 U.S. Cold Temperature Evaluation. October 15,
2008.
---------------------------------------------------------------------------
The September 20, 2011, Federal Register notice cited the August
2010 STEC O26 outbreak and other evidence (at 76 FR 58159--Luchansky et
al., published in 74 J. Food Prot. (2011)7:1054-1064) that demonstrates
that the strain survives ``typical'' cooking employed by some
consumers, and that further risk mitigation was necessary. Researchers
at USDA-ARS examined the effect of various cooking temperatures on
strains of five serogroups (O45, O103, O111, O121, and O145) and E.
coli O157:H7 inoculated into beef steaks that were then tenderized.
Results show that the non-O157 STECs exhibited thermal inactivation
similar to that for E. coli O157:H7.\5\ In another study (Duffy et al.,
2006), STEC O26 also showed similar thermal tolerance to E. coli
O157:H7.
---------------------------------------------------------------------------
\5\ Luchansky J.B., Shoyer B.A., Call J., Schlosser W., Shaw W.,
Bauer N., Latimer H., Porto-Fett A. 2012. Fate of Shiga-toxin
producing O157:H7 and non-O157:H7 Escherichia coli cells within
blade-tenderized beef steaks after cooking on a commercial open-
flame gas grill. Journal of Food Protection. 75:62-70.
---------------------------------------------------------------------------
Equivalency and Implementation Concerns of Foreign Governments
Comment: Several commenters noted that the September 20, 2011,
Federal Register notice states (at 76 FR 58161, col. 1-2): ``For
imported products tested at port of entry, if the product tests
positive at the second stage and has not been held at the import
establishment, it will be subject to recall. If the product has been
held, the product will be refused entry. As always, product
subsequently presented for import inspection from the same foreign
country and establishment will be held at the official import
establishment pending results.'' These commenters asked whether FSIS
intended to treat imported product tested for non-O157 STEC differently
from such product tested for E. coli O157:H7.
Several trade associations and foreign governments addressed
various topics relating to the treatment of imported products at port
of entry, the equivalency of foreign inspection systems, and United
States obligations under World Trade Organization agreements.
Governments and industry trade groups expressed concern that the new
non-O157 STEC policy may violate the United States' obligations under
the Agreement on Sanitary and Phytosanitary (SPS) Measures. Finally,
governments and trade associations questioned the adequacy of the FSIS
risk profile with respect to how it addresses characteristics of non-
O157 STEC.
Response: Consistent with FSIS's procedures for testing for E. coli
O157:H7 in imported product, if a product offered for import tests
positive at port of entry for non-O157 STEC in the screen test and has
not been held at the import establishment, it will not be subject to
recall. However, if the product is still at the import establishment,
FSIS will retain the product until it is confirmed negative.
If the product is confirmed positive and has been held by the
establishment or retained by FSIS at the import establishment, FSIS
will refuse entry of the product. If the confirmed-positive product has
not been held at the import
[[Page 31980]]
establishment, FSIS will request that the importer of record recall the
product.
FSIS has notified its trading partners about the new non-O157 STEC
testing policy. The Agency has committed to video conferencing and
teleconferencing exchanges to assist foreign governments in
understanding the policy and how it applies to them. The Agency expects
countries that export products to the United States to address non-O157
STEC under existing agreements and to prevent contamination of their
raw beef products with these adulterants. Foreign countries may use any
method that will ensure, with reasonable confidence, that products that
they export to the United States will not be contaminated with
detectable non-O157 STEC. Because of the nature of non-O157 STECs, FSIS
would not exclude any country importing product subject to testing from
non-O157 STEC verification testing by FSIS.
Finally, the Agency has assessed scientific data from several
fields on the risk posed by non-O157 STECs and determined that these
pathogens are adulterants under the FMIA. To make this determination,
the Agency prepared a risk profile, which has been independently peer-
reviewed in accordance with Office of Management and Budget (OMB)
guidelines. Both CDC and FDA reviewed the document and supported FSIS's
approach.
The risk profile, in its final version, incorporates CDC data that
show that the organisms for which FSIS will be testing are known to
cause more than 80 percent of human illnesses attributable to non-O157
STECs in the United States.
In addition, FSIS refined the risk profile substantially in
response to comments that were received during peer review.
Accordingly, the risk profile represents the best characterization of
the science associated with the risk from the specified non-O157 STECs.
One commenter raised a concern about the attribution of a non-O157
STEC outbreak in 2007 to a beef product. This outbreak was included in
the risk profile.
CDC has information, including a May 21, 2010, memo, stating that,
``The preliminary data in the table were obtained primarily from
reports voluntarily made by state health departments to CDC. In 2010,
we supplemented NORS [National Outbreak Reporting System] data from the
on non-O157 STEC outbreaks by contacting state and federal health
agencies, by reviewing the scientific literature, and by other
methods.'' The data reported in the memo may be more complete than the
data submitted by the reporting agency to the Foodborne Disease
Outbreak Surveillance System (FDOSS), which is a component of NORS. In
the memo, CDC listed the confirmed or suspected vehicle for this
outbreak as ground beef. This was based on a posting on the North
Dakota State Health Department Web site.
FSIS recognizes that the availability of attribution data for the
non-O157 STECs is partially a function of the number of clinical
laboratories that test for the pathogens, as well as of the robustness
of epidemiological investigations. In this case, however, the only
available information suggests that the non-O157 STEC outbreak may have
been linked to a beef product.
Summary of Changes and Clarifications Made in Response to Comments
As noted earlier in this document, in response to comments on the
September 20, 2011, notice (76 FR 58157), FSIS extended the public
comment period from November 21, 2011, to December 21, 2011 (76 FR
72331; Nov. 23, 2011). Also in response to public comments, FSIS held a
technical meeting December 1, 2011, to solicit additional comments.
FSIS later moved the implementation date of the non-O157 STEC
verification policy for beef manufacturing trimmings to June 4, 2012
(77 FR 9888; Feb. 21, 2012). The purpose of the delay in implementation
was to allow the regulated establishments time to effect any necessary
changes in their food safety systems, including process control
procedures, and to allow time for improvements in testing methods.
In addition, in response to comments, the Agency made available to
foreign governments reagents used in the FSIS method. To allay other
concerns of foreign governments, the Agency affirmed that it would
treat incoming foreign product in the same way that it treats such
product FSIS tests for E. coli O157:H7.
On the matter of using indicator organisms, FSIS has affirmed that
testing of source materials of raw, non-intact beef products for STEC
to verify process controls can be effective if the materials are
sampled at sufficiently high frequencies. However, FSIS has clarified
that E. coli O157:H7 is not an index organism for non-O157 STEC.
In response to questions, FSIS has clarified that establishments
are not required to take corrective actions in response to FSIS screen
positive results. However, FSIS has also clarified that if
establishments find product positive for non-O157 STECs in their screen
tests and do not conduct further testing to confirm that the product is
negative, FSIS will consider the product positive for non-O157 STECs,
just as FSIS considers product that screens positive for E. coli
O157:H7 to be positive if an establishment does not conduct further
testing.
Finally, the Agency has finalized the risk profile on the non-O157
STECs and has incorporated relevant information conveyed by commenters.
Executive Order 13175
The policy discussed in this notice does not have Tribal
Implications that preempt Tribal Law.
USDA Nondiscrimination Statement
The U.S. Department of Agriculture (USDA) prohibits discrimination
in all its programs and activities on the basis of race, color,
national origin, gender, religion, age, disability, political beliefs,
sexual orientation, and marital or family status. (Not all prohibited
bases apply to all programs.) Persons with disabilities who require
alternative means for communication of program information (Braille,
large print, audiotape, etc.) should contact USDA's Target Center at
202-720-2600 (voice and TTY).
To file a written complaint of discrimination, write USDA, Office
of the Assistant Secretary for Civil Rights, 1400 Independence Avenue
SW., Washington, DC 20250-9410 or call 202-720-5964 (voice and TTY).
USDA is an equal opportunity provider and employer.
Additional Public Notification
Public awareness of all segments of rulemaking and policy
development is important. Consequently, FSIS will announce it on-line
through the FSIS Web page located at--https://www.fsis.usda.gov/regulations_&_policies/Interim_&_Final_Rules/index.asp.
FSIS also will make copies of this Federal Register publication
available through the FSIS Constituent Update, which is used to provide
information regarding FSIS policies, procedures, regulations, Federal
Register notices, FSIS public meetings, and other types of information
that could affect or would be of interest to our constituents and
stakeholders. The Update is communicated via Listserv, a free email
subscription service consisting of industry, trade, and farm groups,
consumer interest groups, allied health professionals, scientific
professionals, and other individuals who have requested to be included.
The Update also is available on the FSIS Web page. Through Listserv and
the Web page, FSIS is able to provide information to a much broader,
more diverse audience. In addition, FSIS offers an email subscription
service which provides
[[Page 31981]]
automatic and customized access to selected food safety news and
information. This service is available at https://www.fsis.usda.gov/News_&_Events/Email_Subscription/. Options range from recalls,
export information, regulations, directives, and notices. Customers can
add or delete subscriptions themselves, and have the option to
password-protect their accounts.
Done at Washington, DC, May 25, 2012.
Alfred V. Almanza,
Administrator.
[FR Doc. 2012-13283 Filed 5-29-12; 4:15 pm]
BILLING CODE 3410-DM-P